Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ESMC OTCMKTS:RSLSD NASDAQ:TMED NASDAQ:VIVE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeESMCEscalon Medical$0.35+8.1%$0.32$0.11▼$0.46$2.60M0.37861 shs140 shsRSLSDReShape Lifesciences$0.00$2.91▼$82.80$1.90M2.031,362 shs6,500 shsTMEDT. Rowe Price Health Care ETF$25.22+1.1%$0.00$24.27▼$25.27$10.09M-1.053,767 shs932 shsVIVEViveve Medical$0.00$0.00▼$0.02$1K0.143,146 shsN/A10 Stocks Set to Soar in Summer 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceESMCEscalon Medical+8.12%+8.12%-16.67%+76.77%+145.61%RSLSDReShape Lifesciences0.00%0.00%0.00%0.00%0.00%TMEDT. Rowe Price Health Care ETF+0.77%-0.83%+2,494,999,900.00%+2,494,999,900.00%+2,494,999,900.00%VIVEViveve Medical0.00%0.00%0.00%-50.00%-66.67%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationESMCEscalon MedicalN/AN/AN/AN/AN/AN/AN/AN/ARSLSDReShape LifesciencesN/AN/AN/AN/AN/AN/AN/AN/ATMEDT. Rowe Price Health Care ETFN/AN/AN/AN/AN/AN/AN/AN/AVIVEViveve MedicalN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceESMCEscalon Medical 0.00N/AN/AN/ARSLSDReShape Lifesciences 0.00N/AN/AN/ATMEDT. Rowe Price Health Care ETF 0.00N/AN/AN/AVIVEViveve Medical 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookESMCEscalon Medical$11.98M0.22$0.04 per share9.71N/A∞RSLSDReShape Lifesciences$610K0.00N/A0.08$341.84 per share0.00TMEDT. Rowe Price Health Care ETFN/AN/AN/AN/AN/AN/AVIVEViveve Medical$6.83M0.00N/AN/AN/ANaNCompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateESMCEscalon Medical-$130K$0.057.00∞N/A4.70%45.60%12.66%N/ARSLSDReShape Lifesciences-$81.15MN/A0.00N/AN/A-668.58%-163.22%-52.10%N/ATMEDT. Rowe Price Health Care ETFN/AN/A0.00∞N/AN/AN/AN/AN/AVIVEViveve MedicalN/AN/A0.00N/AN/AN/AN/AN/AN/ALatest VIVE, RSLSD, ESMC, and TMED EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q3 2025ESMCEscalon MedicalN/A$0.02N/A$0.02N/A$3.47 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthESMCEscalon MedicalN/AN/AN/AN/AN/ARSLSDReShape LifesciencesN/AN/AN/AN/AN/ATMEDT. Rowe Price Health Care ETFN/AN/AN/AN/AN/AVIVEViveve MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioESMCEscalon Medical0.141.921.23RSLSDReShape Lifesciences0.051.171.07TMEDT. Rowe Price Health Care ETFN/AN/AN/AVIVEViveve MedicalN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipESMCEscalon MedicalN/ARSLSDReShape LifesciencesN/ATMEDT. Rowe Price Health Care ETFN/AVIVEViveve MedicalN/AInsider OwnershipCompanyInsider OwnershipESMCEscalon Medical1.90%RSLSDReShape LifesciencesN/ATMEDT. Rowe Price Health Care ETF11.10%VIVEViveve Medical5.73%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableESMCEscalon Medical407.42 million7.27 millionNot OptionableRSLSDReShape Lifesciences50354,000N/ANot OptionableTMEDT. Rowe Price Health Care ETFN/A400,000N/AN/AVIVEViveve Medical7010.67 millionN/ANot OptionableVIVE, RSLSD, ESMC, and TMED HeadlinesRecent News About These CompaniesSharing medical andOctober 25, 2024 | news-medical.netNViveve Medical Inc (VIVE)July 24, 2024 | investing.comIncontinence Devices Pipeline Research Report 2024: Stages of Development, Segments, Region and Countries, Regulatory Path and Key CompaniesJuly 19, 2024 | finance.yahoo.comVaginal Rejuvenation Is Big BusinessJuly 19, 2024 | ca.style.yahoo.com5-Alpha Reductase Deficiency Global Market Report 2024: A $1.94 Billion Projected Market in 2028April 17, 2024 | finance.yahoo.comInMode Responds To BTL Petition for Inter Partes Review Of Patent InMode Is Asserting Against BTLApril 15, 2024 | finance.yahoo.comViveve Medical Stock (OTC:VIVE), Analyst Ratings, Price Targets, PredictionsFebruary 23, 2024 | benzinga.comThe Best Medical Billing Services of 2024January 19, 2024 | business.comBVIVE Viveve Medical, Inc.July 29, 2023 | seekingalpha.comInMode Expands Women's Health and Wellness Market Footprint through Acquisition of Viveve PatentsJuly 25, 2023 | finance.yahoo.comVIVE - Viveve Medical, Inc.June 14, 2023 | uk.finance.yahoo.comViveve Medical, Inc. (VIVE)February 24, 2023 | finance.yahoo.comViveve Medical announces study result from PURSUIT clinical trial to treat female stress urinary incontinenceJanuary 20, 2023 | pharmabiz.comPWhy Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionJanuary 17, 2023 | msn.comViveve Medical, Inc.: Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary IncontinenceJanuary 17, 2023 | finanznachrichten.deViveve crashes ~60% as company decides to delist, explore sale after trial failsJanuary 17, 2023 | seekingalpha.comViveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary IncontinenceJanuary 17, 2023 | finance.yahoo.comViveve Medical Seeks Strategic Alternatives After Failed Stress Urinary Incontinence TrialJanuary 17, 2023 | finance.yahoo.comWhy Is Viveve Medical (VIVE) Stock Down 69% Today?January 17, 2023 | investorplace.comViveve Medical, Inc. (NASDAQ:VIVE) Q3 2022 Earnings Call TranscriptDecember 29, 2022 | insidermonkey.comMedia Sentiment Over TimeVIVE, RSLSD, ESMC, and TMED Company DescriptionsEscalon Medical OTCMKTS:ESMC$0.35 +0.03 (+8.12%) As of 07/8/2025 09:30 AM EasternEscalon Medical Corp. engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and Pachymeter that measures the thickness of cornea. The company also provides Ispan Intraocular Gases, such as C3F8 and SF6 that are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery; and AXIS Image management system for managing ophthalmic diagnostic images through the web browser from various devices. In addition, it markets disposable surgical packs used in vitreoretinal surgery, including packs that aid surgeons in the process of injecting and extracting silicone oil. Further, the company engages in the manufacturing and distribution of patented disposable universal gas kit, which delivers the gas from the canister to the patient. It sells its products to medical institutions through independent sales representatives, network of distributors, and internal sales employees. Escalon Medical Corp. was incorporated in 1987 and is headquartered in Wayne, Pennsylvania.ReShape Lifesciences OTCMKTS:RSLSDReShape Lifesciences Inc., a medical device company, focuses on the design, development, and commercialization of technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. The company's product portfolio includes ReShape vBloc, a therapy that enables patients to feel full and eat less by intermittently blocking hunger signals on the vagus nerve; ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without permanently changing patient anatomy; and Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in October 2017. ReShape Lifesciences Inc. was founded in 2002 and is headquartered in San Clemente, California.T. Rowe Price Health Care ETF NASDAQ:TMED$25.22 +0.27 (+1.08%) As of 02:55 PM EasternThe T. Rowe Price Health Care ETF (TMED) is an exchange-traded fund. The fund's investment portfolio concentrates primarily on health care equity. TMED is an actively managed ETF, aiming to outperform its respective sector index TMED was launched on Jun 11, 2025 and is issued by T. Rowe Price.Viveve Medical NASDAQ:VIVEViveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Tesla Stock Could Accelerate on New EV Tax Legislation SoundHound Rises as Short Sellers Exit and AI Demand Grows Why Marvell Could Be the Smartest AI Bet Under $80 Autodesk Stock Ready to Rip? Q3 May Be the Turning Point Amazon's Prime Day Pullback Meets Bullish Golden Cross Signal Palantir’s Revenue Surge to $1B: Growth vs. Valuation Chime Financial: Analysts Ring In—And It’s a Buy Is Fortinet Ready to Break Out After Months of Consolidation? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
